rs4648174
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001135651.3(EIF2AK2):c.241-206A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.308 in 152,080 control chromosomes in the GnomAD database, including 8,265 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.31 ( 8265 hom., cov: 32)
Consequence
EIF2AK2
NM_001135651.3 intron
NM_001135651.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.533
Publications
6 publications found
Genes affected
EIF2AK2 (HGNC:9437): (eukaryotic translation initiation factor 2 alpha kinase 2) The protein encoded by this gene is a serine/threonine protein kinase that is activated by autophosphorylation after binding to dsRNA. The activated form of the encoded protein can phosphorylate translation initiation factor EIF2S1, which in turn inhibits protein synthesis. This protein is also activated by manganese ions and heparin. The encoded protein plays an important role in the innate immune response against multiple DNA and RNA viruses. [provided by RefSeq, Jul 2021]
EIF2AK2 Gene-Disease associations (from GenCC):
- leukoencephalopathy, developmental delay, and episodic neurologic regression syndromeInheritance: AD Classification: STRONG, MODERATE Submitted by: Illumina, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- early-onset generalized limb-onset dystoniaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dystonia 33Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.39 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.308 AC: 46811AN: 151962Hom.: 8266 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
46811
AN:
151962
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.308 AC: 46817AN: 152080Hom.: 8265 Cov.: 32 AF XY: 0.310 AC XY: 23068AN XY: 74324 show subpopulations
GnomAD4 genome
AF:
AC:
46817
AN:
152080
Hom.:
Cov.:
32
AF XY:
AC XY:
23068
AN XY:
74324
show subpopulations
African (AFR)
AF:
AC:
5578
AN:
41502
American (AMR)
AF:
AC:
5008
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
AC:
1540
AN:
3472
East Asian (EAS)
AF:
AC:
1065
AN:
5172
South Asian (SAS)
AF:
AC:
1127
AN:
4814
European-Finnish (FIN)
AF:
AC:
4525
AN:
10566
Middle Eastern (MID)
AF:
AC:
110
AN:
294
European-Non Finnish (NFE)
AF:
AC:
26801
AN:
67968
Other (OTH)
AF:
AC:
723
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1563
3126
4690
6253
7816
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
470
940
1410
1880
2350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
811
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.